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ABSTRACT 
Total penetration of :1-fluorouracil (FUl through human and hairle~li mouse skin was 
measured in vitro and the results were compared using radioactively labelled drug and a gas 
chromatographic method specific for the free F molecule. Both methods were used to 
determine whether metabolism. either in t he skin during penetrat ion or in the penetration 
wells. could have affected the percent penetration as calculated by the radioactivity method . 
The resu lts indicate significantly greater drug penetration in the mouse sa mples using both 
methods of detection. with somewhat greater va ria! ions between identical samples occurrinl{ 
wi th the chroma tographic method. The percent penetrating the human samples. approxi-
mately J :2 percent arter 20 hr. agreed with the previously reported in vivo data. These s tudies 
indicate that further in vitro studies may be useful to study the factors affecting the 
penetration of FU when a ppl ied topically in a variety of skin diseases. 
' 5-lluorouracil has been demonstrated to have 
significant biologic activity whe n applied topically 
in a wide variety of skin diseases. Nurse [ll was the 
first to report evidence of activity of several anti-
metabolites, including FU. on epid erma l strue-
tures. Soon thereafter topical applicat ion of FU 
was shown to be effective in ac tinic keratoses [:2 J 
... and epithel ial neoplasms [:1]. A relatively recent 
report [41 indicates satisfactory control of psoria ti c 
plaques following topical FU therapy. 
To date. only a s ingle study by Dill aha et al [5 J 
has been directed towards the per(·uta neous a b-
sorption of FU. This study utilized radiola belled 
drug and measured excret10n of radioactivity in the 
urine following topical appl ication . Since FU is 
known to be convened tn vivo to the nucleoside 
and nucleotide. which s ti' l retain the 14C label [6, 
71. this is a relatively nonspecific determination 
which could not accoun t for metabolic alteration of 
t h e drug at the site of absorption. 
This report describes the comparison of penetra-
tion of FU through human and hairless mouse skin 
in vitro using radio labelled drug and subsequent 
' liquid scintillation counting. and a gas-liquid 
chromatographic method of ana lysis specific for 
the free FU molecule. Dill'erences between the two 
methods were not found to be s ta tistically signifi-
cant and the percent penetration of FU in the 
human skin samples agreed with the results by 
Dillaha [5 1. 
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MATERIAL.8 A'I;O METHODS 
Reagent.~. All chemical~ and solvents used were ()f 
analytical reagent-grade and water was !(lass-double-dis-
tilled. 
Preparatwn u( exctsed skin samples. Undamaged 
human s kin was obtained from the upper areas of 
surgically amputated leg~. while hau less mouse s km was 
obtained from the back:. of ~- to 4-month-old animals 
which had been sacrificed bv ether mhalation. The ti~­
sues were cut into portions a~d stored a t - 17° to 22" C 
in airtight containers. They were thawed at room tem-
pera! ure I h prior to use. The fat was carefully dissected 
from the bottom of the dermis of the human skin samples 
which were then applied dermis side down to a glass 
penetration well as described in a previous paper [8 ]. 
Hairless mouse s kin was used without dtssection since it 
easily ~eparated from the underly ing muscle and there 
was little subcutaneous fat. This was applied dermis side 
down to the glass wells in the same manner as the human 
skin samples. 
All specimens were placed in a cham ber controlled at 
:!3° C drv bulb and 30° C wet bulb. The wells were fi lled 
with nor;,al saline which bathed the d ermal side of the 
skin samples. and open plastic containers (cylinders). 1.5 
em in diameter. were attached to t he epidermis by Duco• 
cemen t. 0.01- 0.02 ml of an appropriate FU solution in 
propylene glycol was added to the skin 111 these plastic 
containers. 
Aliquots of the solution in the wells bathing the dermts 
were taken at regular mtervals over a 24-hr period and 
analyzed for FU ustng one of the methods descnbed 
below. After each withdrawal, an equal volume of fresh 
saline wao replaced in the wells and the PU penetration 
was calculated over the time interval. 
Radioactiuit_\ studie.,. 5-lluorouracii-2"C (interna -
tional Chemical and ::\uclear. lrvine. California; spec. 
act. 25 mc/ mM 1 was added to propylene glycol along wtth 
unlabelled PU to make a 4"f solut ion with approximately 
10 . 108 disintegratiuns/min/.01 ml or solution . 0.01 0.02 
ml of this solution was a J>plied to the skin sample,.,. 
l.O-ml a liquots were taken from lhe penetration wells at 
specific intervals and diluted wit h Bray's solution for 
subsequen t liquid scintillation counting . Standard proce-
dures were used to determine 1 he quenching of the 
samples. 
Gas chromatographu: .Hudies 0.0 1- 0.02 ml of a 4rf 
solution of FU in propylene J:lycol was applied to the s km 
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samples as described earlier. Aliquot::. were removed at 
the appropnate intervals and suhjet·ted to gas chromato-
graphiC analysts. Thb involve!. the extraction of the free 
FL" from the aqueou;. ;;ample,. into a propanol ether 
m•xture. reaction wnh a denviuzin~ reagent§ lO form the 
di -tnmethylsily derivnti\' E'. tullcmed hy quantitation 
usinJ( a tlame ionization detector nnd un internal s~an­
dard. Samples may be collected and froLen until rend) 
ror analysis. 'the deta1h. ol the pmcedure appear eJ,e-
where 191. 
R£Sli.TS 
Table I indicateli the result:. from penetratton 
studies applying 0.02 ml ot a 4t, Rolut ion ofF to 4 
human skm and 4 ha1rless mouse samples. Ali -
quots were removed from the penetration wells 
between :JO min and 24 hr ancl were analyzed hy 
either the liquid scintillation method (L C) or the 
gas chromaLOgraphic method IGLCI. The cumula-
tive percent penetrated at each time represents the 
mean ul the four ample::.. Table U compares the 
penetration of 0.01 ml of a 4o:; solution applied toR 
human skin and 5 mouse samples after 20 hr. 
For comparative purposes with other molecules. 
Table 111 expresses the mean 20-hr data as molar 
transepidermal fluxes of FU per unit time. 
J)ISCUHSIOI" 
The results indicate fairly high penetration of 
FU throu~rh excised human and hairless mouse 
skin as evidenced by both method::. of detectiOn. 
The rate of penetration of FC was of the same order 
of magnitude in both species, but the total pene· 
tration wa significantly higher in the mouse skin 
sample . The percent penetration is of the same 
order of magnitude as that calculated by Dillaha 
15] from urinary excret1on data following topical 
ap plication of FU-2- 1'C on five patients. H e had 
calculated a 10-15 percent penetration which 
agrees well with our values of 13 percent and 11 
percent calculated by the two different analytical 
methods. The in vivo penetration must be viewed 
cautiously, however. because of the large reported 
differences in the urinary excretion of total radio-
activity llO] following Fll administration by differ· 
ent routes and dosage schedules. 
Considerable variability in penetration b~tween 
human samples obtained from adjacent areas of 
the same leg or between mouse specimens from 
animals of the same age and genetic backi(Tound 
doe;. exist . but these data are typical of the 
' 'ariabiltty in mo t studie~> which quantitate percu -
taneou!> absorption 1111. This variability, which is 
!(Teater "1th the chromatographiC procedure. is 
much greater than the 'ariabilit) of the assay 
procedures. Both analytical techniques were uti-
lized to determine whether metabolism. either in 
the skin during penetrat ion or in the well fo llowing 
§I\:. 0-bis(trimetbylsilyf)triOuoroacetamide conlllin-
ing 1 '~ trimetbylchlorosifane 18 'TFA with 1n; TMr:. 
Pierce Chemical Co .. Rockford. lllinmsl. 
TABLE I 
C'umulaiiLI' percent ppnetratwn oi Fl " 
Humun Skm ~!OUst' :-.kan 
rime 
- -r- r:u··-I.S!' ' LSC• nu·· 
:wmin 1.~ ).;, 1.1 1.:1 
lhr t.:l ~.:! 1.8 2.0 
2 hr 2.0 ~.li 2.9 ~.6 
:1 hr ., -
-·· 
:\. 1 5..1 :\.i"l 
fi hr 4.() :1.(1 8.5 I J.i 
Ill hr 8.:1 :;,; 16.i 19 j 
~I hr 1:!.9 6 I 22.6 '30.6 
0.02 ml ol a 4' solutum wa~c> applied to the epidermis. 
All human sample!> were I rom adJarent areas of the same 
leg. All values represent a mean ol four samples. 
• Liquid scintillut ion l'ount mg 
• Ga.-. liquid chromato~raph:. 
TABLE 11 
Mean 20-hr penetratwn data 
--
Human Skin \lnu>P Sk•n 
---Sum pi!'' LS\ GLC' l~'iC tax 
I I ( I r· I r •I 
- 1-
I -l.:l 6.i :.!:l. J 4:1.0 
2 It .:l IU I 1.2 16.4 
'I t:l.l 12.!1 :1:1.1 l'i.:l 
-1 28.1 6. 1 26.;; 1:1.5 
" 
5.:1 1.9 :,~. I :\9.7 
li 17.:! 19.:1 
- -
7 6.:1 6.i -
-
I{ 'i.:! 1:!.5 - -
9 - 40. 1 - -
Mean 11 .6 z i .:i 1:3.4 10.1 ~"-~ ~ i .9 2.>.9 :t 12.6 
,.. S.D. 
0.01 mf of a 41; soluuun was applied to the epidermis. 
Sampleb 1-1 were from one leg; samples 5-9 were from 
another leg. 
TABLE 1J1 
Mean 20-hr samples expre.\~ed a~ flux per unrt time 
~ample Method Flux· 
mnJe, cm 'Jhr 
Human ~kin Liquid ~cintillut ion 1.09 to ' 
Human likm Gn~ chmmatugra1>~11c 1.26 w· 
Mou~eskin Liquid "l' inttllutum 2.:,; w• 
1\1ou~,.km Go!< rhrumotogrnphtc :!A.J Ill . 
Ml'an 20-hr data from Table II 
• Skm area expu,.ed In drug Wll'- 1.6:3 em'. 
penetration. could be occurrin~r since the chro-
matographic method measures on!) the free F'U. 
The differences in penetration between methods 
were not statistically significant; however. a few nf 
the indi'"idual experiments showed decreases in 
the cumulative percent penetrated at earlier times 
using the chromatol{faphic method. This could 
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very likely he due to "metabolism" by soluble 
enzymes in the penetratton wells. 
The major metabolism of Fl' takes place in· 
tracellularly and involve. anabolic ehanj!e, in the 
n1olecule to form fi.f1uorouridine (FUR) and 5-flu-
oro-2'-deoxyuridine-5' monophosphate (FdUMP). 
which is believed to be the actl\l' lorm or thi!\ 
metabolite 16. i). ~ince the anutumor artl\·ity haR 
been related to FdtJMP. tht!. ma' he the critical 
compound to quantitate tn studies ol topical Fl' 
therapy. In principle, this compound would be too 
tmlar to penetrate normal !ikin ellectt\"el~· . but it 
.:ould be formed intracellular!\• after pt>netration ul 
FL'. ' ince the 14C label would be retainl'd by these 
metabolites. penetration studies u~ing analyllcal 
met hods specific for F'tl, PUR, and FdUMP in 
normal and diseased kin could he u~;elul in the 
as!>essment of the dimcal acth ity of topicall~ 
applied FL 
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